Medda Pierpaolo, Toni Cristina, Perugi Giulio
From the *Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; and †Institute of Behavioral Science "G. De Lisio," Carrara-Pisa, Italy.
J ECT. 2014 Dec;30(4):275-82. doi: 10.1097/YCT.0000000000000160.
The "ideal" mood stabilizer has been defined as an agent displaying demonstrated efficacy for the acute treatment and long-term prevention of both mania and depression. On the basis of a selective and an extensive review of the existing literature primarily focused on prospective and controlled studies, we discuss the potential mood-stabilizing effects of electroconvulsive therapy (ECT) and its efficacy for the acute treatment of bipolar depressive and mixed-manic states and the prevention of all types of recurrences of bipolar disorder (BD). We conclude that ECT should be considered an effective acute treatment for the depressive and manic-mixed states of BD, as ECT displays response and remission rates superior to those of other treatment approaches, even in severe and treatment-resistant cases. From this point of view, its clinical mood-stabilizing effects are clearly superior compared with other pharmacological approaches because most treatments that alleviate bipolar depression can cause mania, hypomania, mood instability, or rapid cycling and treatments that can control mania can induce or precipitate depressive symptoms or episodes. The ECT-induced mania is rare, and there are no data suggesting possible long-term mood destabilization, including cycle induction or acceleration. Conversely, several case reports and open trials reported a significant reduction in morbidity among patients experiencing rapid-cycling BD. Regarding relapse prevention, c-ECT and m-ECT are considered as appropriate therapies for treatment-resistant patients exhibiting high rates of depressive or mixed relapse. Further investigation is necessary to identify the frequency and duration of continued treatment after a successful index course of ECT.
“理想”的心境稳定剂被定义为一种对躁狂和抑郁的急性治疗及长期预防均显示出疗效的药物。在对主要聚焦于前瞻性和对照研究的现有文献进行选择性和广泛回顾的基础上,我们讨论了电休克治疗(ECT)潜在的心境稳定作用及其对双相抑郁和混合躁狂状态的急性治疗效果以及预防双相情感障碍(BD)所有类型复发的疗效。我们得出结论,ECT应被视为BD抑郁和躁狂混合状态的一种有效急性治疗方法,因为ECT显示出的反应率和缓解率优于其他治疗方法,即使在严重及难治性病例中也是如此。从这一角度来看,其临床心境稳定作用明显优于其他药物治疗方法,因为大多数缓解双相抑郁的治疗可能会引发躁狂、轻躁狂、情绪不稳定或快速循环,而能控制躁狂的治疗可能会诱发或加重抑郁症状或发作。ECT诱发的躁狂很少见,且没有数据表明可能存在长期心境不稳定,包括诱发或加速循环。相反,一些病例报告和开放性试验报告称,快速循环型BD患者的发病率显著降低。关于预防复发,c-ECT和m-ECT被认为是对抑郁或混合复发率高的难治性患者的合适治疗方法。有必要进一步研究以确定ECT成功的首次疗程后持续治疗的频率和持续时间。